Follow
Drug research
Drug research encompasses many processes which culminate in the development of drugs and pharmaceuticals. Drug discovery and development is a long and detailed endeavor including extensive research and testing of new drug modalities to ensure they are both safe and effective.
-
SEP 30, 2015 | 9:00 AM
The Warburg effect or aerobic glycolysis is a well-known cancer metabolism phenomenon and serves as an established test for tumor detection with FDG-PET scanning technology. Cancer cells swit...Speaker: Jennifer Molina, PhDSEP 30, 2015 | 7:30 AM
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...SEP 30, 2015 | 7:30 AM
The landscape for treatment options in metastatic castration resistant prostate cancer has changed dramatically since 2010. There have been more therapies approved since 2010 than in the prio...Speaker: Lawrence Karsh MD FACSSEP 22, 2015 | 9:00 AM
DATE: Sept 22, 2015TIME: 9:00am PDT, 12:00PM EDTHeart failure is a complex syndrome and affects over 5.1 Million Americans today with approximately 500,000 new heart failure cases each year. ...Speaker: Peter McCullough, M.D., M.P.H. F.A.C.P., F.A.C.C., F.C.C.P., F.A.H.A., F.N.K.F., F.N.L.A., F.C.R.S.A.Sponsored By: Abbott Molecular Diagnostic, Abbott Molecular DiagnosticSEP 22, 2015 | 8:00 AM
Surface plasmon resonance (SPR) is a sensitive, label-free technique that detects mass changes due to biomolecular interactions on a surface. This versatile method has been used to evaluate t...SEP 16, 2015 | 2:00 PM
Structure-based drug discovery requires expert designers, aided by software that integrates 3D structure visualization and molecular editing with multivariate experimentaland calculated prope...Speaker: Jeff BlaneySEP 16, 2015 | 1:00 PM
In this interactive session, Derek Lowe will be taking questions from the audience in an informal discussion on his work in drug discovery, and his take on the current pharma landscape. Moder...Speaker: Derek LoweSEP 16, 2015 | 12:00 PM
Nanotechnology, the engineering and manufacture of materials at the atomic and molecular scale, is used at BIND Therapeutics to develop novel Accurin™ nanomedicines that utilize cytotoxic age...Speaker: Hagop YoussoufianSEP 16, 2015 | 11:00 AM
Humans are colonized by vast numbers of symbiotic microorganisms whose metabolisms are inextricably intertwined with our own. To understand how chemical transformations performed by the human...Speaker: Emily BalskusSEP 16, 2015 | 10:00 AM
The process by which observations in the laboratory or the clinic are transformed into demonstrably useful interventions that tangibly improve human health is frequently termed "translation."...Speaker: Christopher AustinSEP 16, 2015 | 9:00 AM
Learning Objectives for this presentation - (1) Understand how human genetics can contribute to drug discovery and development. (2) Understand the role of biomarkers and clinical proof-...Speaker: Robert PlengeSEP 16, 2015 | 7:00 AM
As a computational scientist I have been fortunate to work with many collaborators to generate biological data to train and test my models. We are in a position with increasing amounts of dat...Speaker: Sean EkinsSEP 16, 2015 | 6:00 AM
One of the challenges in sustaining innovation in computational molecular design is the need to harness and deliver promising solutions irrespective of their source, without creating new soft...Speaker: Enoch HuangSEP 16, 2015 | 5:00 AM
The antibiotic pipeline is broken, with a dearth of new antibiotics, a collapse in pharmaceutical company research1, and the exhaustion of chemical diversity contained in pharma libraries. "T...Speaker: Mark BlaskovichSEP 10, 2015 | 4:00 AM
The webinar will start at 4am Pacific Time, 7am Eastern Time, 1pm Central European Summer Time, 7pm China Standard Time Extracellular vesicles (EVs) including exosome and microvesi...Speaker: Charles Lai, PhDPresented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life SciencesSEP 03, 2015 | 1:30 PM
Natural preservation is often cited as effective and “safe” alternative to traditional synthetic preservative systems. However, the so-called natural preservatives bring a number...SEP 02, 2015 | 1:30 PM
The world–as microbes perceive it–is composed of physical and chemical stimuli. These stimuli create conditions that result in life or death for microbes, affecting their survival...SEP 02, 2015 | 6:00 AM
Managing microbial contaminants is critical during the manufacturing of biologics, food and beverage to ensure that products meet the high quality product standard as well as staying complian...JUL 22, 2015 | 9:00 AM
DATE: July 22, 2015TIME: 9:00AM PT, 12:00PM ETHuman induced pluripotent stem cells (iPSCs) bring human biology into pre-clinical aspects of drug discovery. iPSC-derived cardiomyocytes have em...Speaker: Blake Anson, PhD , Mathew Brock, PhDSponsored By: Cellular Dynamics, Cellular DynamicsJUN 25, 2015 | 8:00 AM
The emerging field of RNA nanotechnology has led to the utilization of the platform in the field of bionanotechnology as sensing platforms, diverse nanoparticle construction, in vivo computin...Speaker: Daniel JasinskiPresented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life SciencesJUN 24, 2015 | 9:00 AM
Date: Wednesday, June 24th, 2015 Time: 09:00AM PDT, 12:00PM EDT, 4:00PM GMT Solaris™ is a new open-air fluorescence imaging system developed by PerkinElmer, enabling translational in vivo pre...JUN 11, 2015 | 2:00 PM
Clinical laboratories and, indeed, health care overall, are facing potential paradigm shifts in how innovative and higher quality care are delivered to patients. From ever more precise and ac...Speaker: Thomas SparkmanJUN 11, 2015 | 11:00 AM
Consistent accuracy in reporting quantitative viral load results is critically important to patients, their physicians and to the clinical laboratory. In clinical practice, quantitative viral...Speaker: Russell GarlickJUN 11, 2015 | 7:00 AM
Date: Thursday, June 11th, 2015Time: 07:00AM PDT, 10:00AM EDT, 03:00PM BST Alzheimer's disease (AD) is the most common form of dementia with nearly 44 million people affected worldwide. Chara...
SEP 30, 2015 | 9:00 AM
The Warburg effect or aerobic glycolysis is a well-known cancer metabolism phenomenon and serves as an established test for tumor detection with FDG-PET scanning technology. Cancer cells swit...
Speaker:
Jennifer Molina, PhD
SEP 30, 2015 | 7:30 AM
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...
SEP 30, 2015 | 7:30 AM
The landscape for treatment options in metastatic castration resistant prostate cancer has changed dramatically since 2010. There have been more therapies approved since 2010 than in the prio...
Speaker:
Lawrence Karsh MD FACS
SEP 22, 2015 | 9:00 AM
DATE: Sept 22, 2015TIME: 9:00am PDT, 12:00PM EDTHeart failure is a complex syndrome and affects over 5.1 Million Americans today with approximately 500,000 new heart failure cases each year. ...
Speaker:
Peter McCullough, M.D., M.P.H. F.A.C.P., F.A.C.C., F.C.C.P., F.A.H.A., F.N.K.F., F.N.L.A., F.C.R.S.A.
Sponsored By: Abbott Molecular Diagnostic,
Abbott Molecular Diagnostic
SEP 22, 2015 | 8:00 AM
Surface plasmon resonance (SPR) is a sensitive, label-free technique that detects mass changes due to biomolecular interactions on a surface. This versatile method has been used to evaluate t...
SEP 16, 2015 | 2:00 PM
Structure-based drug discovery requires expert designers, aided by software that integrates 3D structure visualization and molecular editing with multivariate experimentaland calculated prope...
Speaker:
Jeff Blaney
SEP 16, 2015 | 1:00 PM
In this interactive session, Derek Lowe will be taking questions from the audience in an informal discussion on his work in drug discovery, and his take on the current pharma landscape. Moder...
Speaker:
Derek Lowe
SEP 16, 2015 | 12:00 PM
Nanotechnology, the engineering and manufacture of materials at the atomic and molecular scale, is used at BIND Therapeutics to develop novel Accurin™ nanomedicines that utilize cytotoxic age...
Speaker:
Hagop Youssoufian
SEP 16, 2015 | 11:00 AM
Humans are colonized by vast numbers of symbiotic microorganisms whose metabolisms are inextricably intertwined with our own. To understand how chemical transformations performed by the human...
Speaker:
Emily Balskus
SEP 16, 2015 | 10:00 AM
The process by which observations in the laboratory or the clinic are transformed into demonstrably useful interventions that tangibly improve human health is frequently termed "translation."...
Speaker:
Christopher Austin
SEP 16, 2015 | 9:00 AM
Learning Objectives for this presentation -
(1) Understand how human genetics can contribute to drug discovery and development.
(2) Understand the role of biomarkers and clinical proof-...
Speaker:
Robert Plenge
SEP 16, 2015 | 7:00 AM
As a computational scientist I have been fortunate to work with many collaborators to generate biological data to train and test my models. We are in a position with increasing amounts of dat...
Speaker:
Sean Ekins
SEP 16, 2015 | 6:00 AM
One of the challenges in sustaining innovation in computational molecular design is the need to harness and deliver promising solutions irrespective of their source, without creating new soft...
Speaker:
Enoch Huang
SEP 16, 2015 | 5:00 AM
The antibiotic pipeline is broken, with a dearth of new antibiotics, a collapse in pharmaceutical company research1, and the exhaustion of chemical diversity contained in pharma libraries. "T...
Speaker:
Mark Blaskovich
SEP 10, 2015 | 4:00 AM
The webinar will start at 4am Pacific Time, 7am Eastern Time, 1pm Central European Summer Time, 7pm China Standard Time
Extracellular vesicles (EVs) including exosome and microvesi...
Speaker:
Charles Lai, PhD
Presented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
SEP 03, 2015 | 1:30 PM
Natural preservation is often cited as effective and “safe” alternative to traditional synthetic preservative systems. However, the so-called natural preservatives bring a number...
SEP 02, 2015 | 1:30 PM
The world–as microbes perceive it–is composed of physical and chemical stimuli. These stimuli create conditions that result in life or death for microbes, affecting their survival...
SEP 02, 2015 | 6:00 AM
Managing microbial contaminants is critical during the manufacturing of biologics, food and beverage to ensure that products meet the high quality product standard as well as staying complian...
JUL 22, 2015 | 9:00 AM
DATE: July 22, 2015TIME: 9:00AM PT, 12:00PM ETHuman induced pluripotent stem cells (iPSCs) bring human biology into pre-clinical aspects of drug discovery. iPSC-derived cardiomyocytes have em...
Speaker:
Blake Anson, PhD
, Mathew Brock, PhD
Sponsored By: Cellular Dynamics,
Cellular Dynamics
JUN 25, 2015 | 8:00 AM
The emerging field of RNA nanotechnology has led to the utilization of the platform in the field of bionanotechnology as sensing platforms, diverse nanoparticle construction, in vivo computin...
Speaker:
Daniel Jasinski
Presented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
JUN 24, 2015 | 9:00 AM
Date: Wednesday, June 24th, 2015 Time: 09:00AM PDT, 12:00PM EDT, 4:00PM GMT Solaris™ is a new open-air fluorescence imaging system developed by PerkinElmer, enabling translational in vivo pre...
JUN 11, 2015 | 2:00 PM
Clinical laboratories and, indeed, health care overall, are facing potential paradigm shifts in how innovative and higher quality care are delivered to patients. From ever more precise and ac...
Speaker:
Thomas Sparkman
JUN 11, 2015 | 11:00 AM
Consistent accuracy in reporting quantitative viral load results is critically important to patients, their physicians and to the clinical laboratory. In clinical practice, quantitative viral...
Speaker:
Russell Garlick
JUN 11, 2015 | 7:00 AM
Date: Thursday, June 11th, 2015Time: 07:00AM PDT, 10:00AM EDT, 03:00PM BST Alzheimer's disease (AD) is the most common form of dementia with nearly 44 million people affected worldwide. Chara...